drugset / Trial / NCT00502970
Short Course of Interferon Treatment in Patients With HCV Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine if a shorter course of interferon and ribavirin therapy will be sufficient in carefully selected patients with chronic hepatitis C virus genotype 3 infection, as compared to the standard length of treatment of 6 months.
Timeline
- Start
- 2004-05
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribavirin | Small molecule | 800 mg | — |
| Subject | Ribavirin | Small molecule | 1200 mg | — |
| Subject | interferon alfa | Protein / enzyme biologic | 3e+06 iu | Subcutaneous |